FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. Under the <i>National Health (Pharmaceutical Benefits) Regulations 2017</i>, the <i>Repatriation Pharmaceutical Benefits Scheme Instrument 2013</i> and <i>MRCA Pharmaceutical Benefits Scheme Instrument 2013</i>, all PBS and RPBS prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client:&nbsp;</b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health and Aged Care to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module


1324 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health and Aged Care true Inferred relationship Some 1570063879

Members
somatropin 10 mg/1.5 mL injection, 1.5 mL
somatropin 10 mg/1.5 mL injection, cartridge
somatropin 10 mg/1.5 mL injection, 10 x 1.5 mL cartridges
somatropin 10 mg/1.5 mL injection, 2 x 1.5 mL cartridges
somatropin 10 mg/1.5 mL injection, 5 x 1.5 mL cartridges
somatropin 10 mg/2 mL injection, 2 mL cartridge
somatropin 10 mg/2 mL injection, cartridge
somatropin 12 mg/1.5 mL injection, 1.5 mL cartridge
somatropin 12 mg/1.5 mL injection, cartridge
somatropin 12 mg/1.5 mL injection, 5 x 1.5 mL cartridges
somatropin 12 mg injection, cartridge
somatropin 12 mg injection, chamber
somatropin 15 mg/1.5 mL injection
somatropin 15 mg/1.5 mL injection, 1.5 mL cartridge
somatropin 15 mg/1.5 mL injection, 1.5 mL
somatropin 15 mg/1.5 mL injection, cartridge
somatropin 15 mg/1.5 mL injection, 5 x 1.5 mL cartridges
somatropin 2 mg injection, chamber
somatropin 20 mg/2.5 mL injection, 2.5 mL cartridge
somatropin 20 mg/2.5 mL injection, cartridge
somatropin 20 mg/2.5 mL injection, 5 x 2.5 mL cartridges
somatropin 24 mg injection, cartridge
somatropin 4 mg injection, vial
somatropin 400 microgram injection, chamber
somatropin 5 mg/1.5 mL injection
somatropin 5 mg/1.5 mL injection, 1.5 mL cartridge
somatropin 5 mg/1.5 mL injection, 1.5 mL
somatropin 5 mg/1.5 mL injection, cartridge
somatropin 5 mg / 1.5 mL injection, 10 x 1.5 mL cartridges (medicinal product pack)
somatropin 5 mg/1.5 mL injection, 2 x 1.5 mL cartridges
somatropin 5 mg/1.5 mL injection, 5 x 1.5 mL cartridges
somatropin 5 mg injection, chamber
somatropin 6 mg/1.03 mL injection, 1.03 mL cartridge
somatropin 6 mg/1.03 mL injection, cartridge
somatropin 6 mg/1.03 mL injection, 5 x 1.03 mL cartridges
somatropin 6 mg injection, cartridge
somatropin 600 microgram injection, chamber
somatropin 800 microgram injection, chamber
tacrolimus 1 mg capsule
tacrolimus 1 mg capsule, 10
tacrolimus 1 mg capsule, 100
tacrolimus 1 mg capsule, 50
tacrolimus 1 mg modified release capsule
tacrolimus 1 mg modified release capsule, 100
tacrolimus 1 mg modified release capsule, 30
tacrolimus 1 mg modified release capsule, 50
tacrolimus 1 mg modified release capsule, 60
tacrolimus 3 mg modified release capsule
tacrolimus 3 mg modified release capsule, 50
tacrolimus 5 mg capsule
tacrolimus 5 mg capsule, 10
tacrolimus 5 mg capsule, 100
tacrolimus 5 mg capsule, 50
tacrolimus 5 mg modified release capsule
tacrolimus 5 mg modified release capsule, 30
tacrolimus 5 mg modified release capsule, 50
tacrolimus 500 microgram capsule
tacrolimus 500 microgram capsule, 10
tacrolimus 500 microgram capsule, 100
tacrolimus 500 microgram capsule, 50
tacrolimus 500 microgram modified release capsule
tacrolimus 500 microgram modified release capsule, 30
tacrolimus 500 microgram modified release capsule, 50
theophylline 133.3 mg/25 mL oral liquid
theophylline 133.3 mg/25 mL oral liquid, 500 mL
theophylline 200 mg modified release tablet
theophylline 200 mg modified release tablet, 100
theophylline 250 mg modified release tablet
theophylline 250 mg modified release tablet, 100
theophylline 300 mg modified release tablet
theophylline 300 mg modified release tablet, 100
timolol 0.5% eye drops
timolol 0.5% eye drops, 2.5 mL
timolol 0.5% eye drops, 5 mL
tolvaptan 15 mg tablet
tolvaptan 15 mg tablet, 10
tolvaptan 15 mg tablet, 28
tolvaptan 15 mg tablet, 7
tolvaptan 30 mg tablet
tolvaptan 30 mg tablet, 10
tolvaptan 30 mg tablet, 28
tolvaptan 30 mg tablet, 7
tolvaptan 15 mg tablet [28] (&) tolvaptan 45 mg tablet [28], 56
tolvaptan 30 mg tablet [28] (&) tolvaptan 60 mg tablet [28], 56
tolvaptan 30 mg tablet [28] (&) tolvaptan 90 mg tablet [28], 56
tramadol hydrochloride 50 mg capsule
tramadol hydrochloride 50 mg capsule, 10 capsules (medicinal product pack)
tramadol hydrochloride 50 mg capsule, 20
tramadol hydrochloride 50 mg capsule, 30
tramadol hydrochloride 50 mg capsule, 50
tramadol hydrochloride 50 mg capsule, 6
tramadol hydrochloride 50 mg capsule, 8
tramadol hydrochloride 50 mg modified release tablet
tramadol hydrochloride 50 mg modified release tablet, 20
tramadol hydrochloride 50 mg modified release tablet, 4
tramadol hydrochloride 50 mg modified release tablet, 60
trastuzumab 150 mg injection, 1 vial
trastuzumab 150 mg injection, vial
trastuzumab 420 mg injection, 1 vial
trastuzumab 420 mg injection, vial
trastuzumab 60 mg injection, 1 vial

Start Previous Page 13 of 14 End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start